Spike Protein News and Research

RSS
Study shows antibody responses persisting 10 months after SARS-CoV-2 infection

Study shows antibody responses persisting 10 months after SARS-CoV-2 infection

SARS-CoV-2 does not infect the entire body in the same way, finds study

SARS-CoV-2 does not infect the entire body in the same way, finds study

GW team to play a role in Sanofi COVID-19 vaccine clinical trial

GW team to play a role in Sanofi COVID-19 vaccine clinical trial

Basigin does not facilitate SARS-CoV-2 entry, say researchers

Basigin does not facilitate SARS-CoV-2 entry, say researchers

Researchers explore how N501Y mutation in SARS-CoV-2 increases viral transmissibility

Researchers explore how N501Y mutation in SARS-CoV-2 increases viral transmissibility

Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo

Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo

Long-lasting B cells do not recognize emerging SARS-CoV-2 variants, shows study

Long-lasting B cells do not recognize emerging SARS-CoV-2 variants, shows study

SARS-CoV-2 variants emerge during humoral immunity phase of acute COVID-19

SARS-CoV-2 variants emerge during humoral immunity phase of acute COVID-19

Two potent SARS-CoV-2 neutralizing antibodies effective against B.1.351 and B.1.1.7 variants

Two potent SARS-CoV-2 neutralizing antibodies effective against B.1.351 and B.1.1.7 variants

Research predicts which mammal species can spread SARS-CoV-2

Research predicts which mammal species can spread SARS-CoV-2

Phase 1 clinical trial shows promising results for monoclonal antibodies against MERS coronavirus

Phase 1 clinical trial shows promising results for monoclonal antibodies against MERS coronavirus

Key mutation sites in the SARS-CoV-2 spike protein modulate antibody and ACE2 affinity

Key mutation sites in the SARS-CoV-2 spike protein modulate antibody and ACE2 affinity

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

GSK-3 inhibitors show promise in treating coronavirus infections

GSK-3 inhibitors show promise in treating coronavirus infections

Researchers develop nanoceutical mask fabric that prevents SARS-CoV-2 transmission

Researchers develop nanoceutical mask fabric that prevents SARS-CoV-2 transmission

Could laser-facilitated epicutaneous vaccination for SARS-CoV-2 be an alternative to intramuscular injection?

Could laser-facilitated epicutaneous vaccination for SARS-CoV-2 be an alternative to intramuscular injection?

How effective has Israel’s SARS-CoV-2 testing and vaccination campaign been against the UK variant?

How effective has Israel’s SARS-CoV-2 testing and vaccination campaign been against the UK variant?

L452R mutation potentially favors adaptive evolution of SARS-CoV-2

L452R mutation potentially favors adaptive evolution of SARS-CoV-2

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

Fooling the novel coronavirus with a fake handshake to inactivate the virus

Fooling the novel coronavirus with a fake handshake to inactivate the virus